PMID- 36148245 OWN - NLM STAT- MEDLINE DCOM- 20220926 LR - 20220927 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 13 DP - 2022 TI - TLR2-induced CD8(+) T-cell deactivation shapes dendritic cell differentiation in the bone marrow during sepsis. PG - 945409 LID - 10.3389/fimmu.2022.945409 [doi] LID - 945409 AB - Sepsis is associated with profound immune dysregulation that increases the risk for life-threatening secondary infections: Dendritic cells (DCs) undergo functional reprogramming due to yet unknown changes during differentiation in the bone marrow (BM). In parallel, lymphopenia and exhaustion of T lymphocytes interfere with antigen-specific adaptive immunity. We hypothesized that there exists a link between T cells and the modulation of DC differentiation in the BM during murine polymicrobial sepsis. Sepsis was induced by cecal ligation and puncture (CLP), a model for human bacterial sepsis. At different time points after CLP, the BM and spleen were analyzed in terms of T-cell subpopulations, activation, and Interferon (IFN)-gamma synthesis as well as the number of pre-DCs. BM-derived DCs were generated in vitro. We observed that naive and virtual memory CD8(+) T cells, but not CD4(+) T cells, were activated in an antigen-independent manner and accumulated in the BM early after CLP, whereas lymphopenia was evident in the spleen. The number of pre-DCs strongly declined during acute sepsis in the BM and almost recovered by day 4 after CLP, which required the presence of CD8(+) T cells. Adoptive transfer experiments and in vitro studies with purified T cells revealed that Toll-like receptor 2 (TLR2) signaling in CD8(+) T cells suppressed their capacity to secrete IFN-gamma and was sufficient to change the transcriptome of the BM during sepsis. Moreover, the diminished IFN-gamma production of CD8(+) T cells favored the differentiation of DCs with increased production of the immune-activating cytokine Interleukin (IL)-12. These data identify a novel role of CD8(+) T cells in the BM during sepsis as they sense TLR2 ligands and control the number and function of de novo differentiating DCs. CI - Copyright (c) 2022 Antoni, Pylaeva, Budeus, Jablonska, Klein-Hitpass, Dudda and Flohe. FAU - Antoni, Anne-Charlotte AU - Antoni AC AD - Department of Trauma, Hand, and Reconstructive Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany. FAU - Pylaeva, Ekaterina AU - Pylaeva E AD - Department of Otorhinolaryngology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. FAU - Budeus, Bettina AU - Budeus B AD - Institute of Cell Biology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. FAU - Jablonska, Jadwiga AU - Jablonska J AD - Department of Otorhinolaryngology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. FAU - Klein-Hitpass, Ludger AU - Klein-Hitpass L AD - Institute of Cell Biology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. FAU - Dudda, Marcel AU - Dudda M AD - Department of Trauma, Hand, and Reconstructive Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany. FAU - Flohe, Stefanie B AU - Flohe SB AD - Department of Trauma, Hand, and Reconstructive Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220906 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Antigens) RN - 0 (Cytokines) RN - 0 (TLR2 protein, human) RN - 0 (Tlr2 protein, mouse) RN - 0 (Toll-Like Receptor 2) RN - 187348-17-0 (Interleukin-12) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - Antigens MH - Bone Marrow MH - CD8-Positive T-Lymphocytes MH - Cell Differentiation MH - Cytokines MH - Dendritic Cells MH - Humans MH - Interferon-gamma MH - Interleukin-12 MH - *Lymphopenia MH - Mice MH - *Sepsis MH - Toll-Like Receptor 2 PMC - PMC9488929 OTO - NOTNLM OT - T cells OT - TLR - toll-like receptor OT - bone marrow OT - dendritic cells OT - differentiation OT - immunosuppression OT - sepsis COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/09/24 06:00 MHDA- 2022/09/28 06:00 PMCR- 2022/01/01 CRDT- 2022/09/23 02:56 PHST- 2022/05/16 00:00 [received] PHST- 2022/07/15 00:00 [accepted] PHST- 2022/09/23 02:56 [entrez] PHST- 2022/09/24 06:00 [pubmed] PHST- 2022/09/28 06:00 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2022.945409 [doi] PST - epublish SO - Front Immunol. 2022 Sep 6;13:945409. doi: 10.3389/fimmu.2022.945409. eCollection 2022.